www.fdanews.com/articles/127124-for-novartis-cambridge-is-a-growth-site
For Novartis, Cambridge Is a Growth Site
May 17, 2010
At a time when many global pharmaceutical companies are paring back research and farming out drug development to smaller biotechnology partners, the Swiss drug maker Novartis AG is accelerating its push to develop products internally.
boston
boston